carmustine has been researched along with antipyrine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Diksic, M; Feindel, W; Mitsuka, S; Nagahiro, S; Sugimoto, S; Yamamoto, YL | 1 |
Blacklock, JB; Blasberg, RG; Dedrick, RL; Doppman, JL; Lutz, RJ; Oldfield, EH; Wright, DC | 1 |
Larson, RE; Moldowan, MJ; Wilson, VL | 2 |
Eller, S; Fung, LK; Grossman, SA; Saltzman, WM; Strasser, JF | 1 |
8 other study(ies) available for carmustine and antipyrine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Neurotoxicity after intracarotid 1,3-bis(2-chloroethyl)-1-nitrosourea administration in the rat: hemodynamic changes studied by double-tracer autoradiography.
Topics: Aminobutyrates; Amygdala; Animals; Antipyrine; Autoradiography; Blood-Brain Barrier; Carbon Radioisotopes; Carmustine; Carotid Arteries; Caudate Nucleus; Cerebral Cortex; Cerebral Hemorrhage; Cerebrovascular Circulation; Deoxyglucose; Dose-Response Relationship, Drug; Electroencephalography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hippocampus; Hypothalamus; Injections, Intra-Arterial; Necrosis; Rats; Rats, Inbred Strains; Thalamus; Tissue Distribution | 1991 |
Drug streaming during intra-arterial chemotherapy.
Topics: Animals; Antineoplastic Agents; Antipyrine; Brain Neoplasms; Carbon Radioisotopes; Carmustine; Carotid Artery, Internal; Infusions, Intra-Arterial; Infusions, Parenteral; Macaca mulatta | 1986 |
A non-invasive method for the study of hepatic drug metabolism in rodents: antineoplastic drug effects on antipyrine metabolism in mice.
Topics: Aminopyrine; Animals; Antineoplastic Agents; Antipyrine; Carmustine; Half-Life; Liver; Male; Mice; Pharmaceutical Preparations; Phenobarbital; Rats; Rats, Inbred Strains; Saliva | 1982 |
Effect of BCNU on antipyrine metabolism in mice.
Topics: Animals; Antipyrine; Carmustine; Chromatography, High Pressure Liquid; Male; Mice; Microsomes, Liver; Rats; Time Factors | 1981 |
Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants.
Topics: Animals; Antipyrine; Autoradiography; Biodegradation, Environmental; Brain; Brain Neoplasms; Carmustine; Drug Implants; Male; Polymers; Rabbits | 1995 |